Lazard Asset Management LLC Decreased Its Medtronic Plc (MDT) Position as Stock Value Declined

May 27, 2018 - By simple simple

Medtronic plc (NYSE:MDT) LogoInvestors sentiment decreased to 1.02 in 2017 Q4. Its down 0.10, from 1.12 in 2017Q3. It fall, as 65 investors sold MDT shares while 427 reduced holdings. 111 funds opened positions while 393 raised stakes. 1.04 billion shares or 2.98% less from 1.07 billion shares in 2017Q3 were reported. Kingfisher Lc reported 10,856 shares or 0.56% of all its holdings. Nikko Asset Management Americas invested in 0% or 2,100 shares. Finemark National Bank & reported 29,064 shares. Haverford Tru has invested 1.68% of its portfolio in Medtronic plc (NYSE:MDT). Stack Financial Mgmt Inc has 167,441 shares for 1.36% of their portfolio. Miller Investment Mgmt Limited Partnership holds 0.62% or 25,165 shares. Meyer Handelman Com accumulated 264,262 shares. 546,046 were accumulated by Westend Lc. Bb&T Securities Limited Liability Company invested in 0.24% or 228,870 shares. Grimes holds 112,136 shares or 0.87% of its portfolio. Gofen & Glossberg Ltd Liability Co Il reported 7,839 shares. Thompson Siegel Walmsley Ltd Com reported 1,962 shares. Eaton Vance, a Massachusetts-based fund reported 1.08M shares. Hartford Financial Mngmt stated it has 1,921 shares or 0.08% of all its holdings. Park Natl Oh has invested 0.25% of its portfolio in Medtronic plc (NYSE:MDT).

Lazard Asset Management Llc decreased its stake in Medtronic Plc (MDT) by 0.71% based on its latest 2017Q4 regulatory filing with the SEC. Lazard Asset Management Llc sold 160,416 shares as the company’s stock declined 4.15% with the market. The institutional investor held 22.57M shares of the electromedical & electrotherapeutic apparatus company at the end of 2017Q4, valued at $1.82B, down from 22.73M at the end of the previous reported quarter. Lazard Asset Management Llc who had been investing in Medtronic Plc for a number of months, seems to be less bullish one the $116.97B market cap company. The stock decreased 0.79% or $0.69 during the last trading session, reaching $86.3. About 4.69 million shares traded. Medtronic plc (NYSE:MDT) has declined 3.54% since May 27, 2017 and is downtrending. It has underperformed by 15.09% the S&P500.

Lazard Asset Management Llc, which manages about $52.81B US Long portfolio, upped its stake in Mks Instruments (NASDAQ:MKSI) by 78,320 shares to 259,880 shares, valued at $24.56M in 2017Q4, according to the filing. It also increased its holding in Microchip Techn (NASDAQ:MCHP) by 119,600 shares in the quarter, for a total of 666,100 shares, and has risen its stake in Citizens Fin Gr (NYSE:CFG).

More notable recent Medtronic plc (NYSE:MDT) news were published by: Seekingalpha.com which released: “Medtronic Should Focus On Aggressive Deleveraging” on May 15, 2018, also Seekingalpha.com with their article: “Medtronic plc 2018 Q4 – Results – Earnings Call Slides” published on May 24, 2018, Globenewswire.com published: “Medtronic Announces New Paid Family Care Leave Benefits” on May 01, 2018. More interesting news about Medtronic plc (NYSE:MDT) were released by: Benzinga.com and their article: “Earnings Roundup for Medtronic” published on May 23, 2018 as well as Globenewswire.com‘s news article titled: “Medtronic Announces 2018 Institutional Investor and Analyst Meeting and Webcast” with publication date: May 18, 2018.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 8 analysts covering Medtronic (NYSE:MDT), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Medtronic had 12 analyst reports since December 12, 2017 according to SRatingsIntel. As per Monday, February 5, the company rating was maintained by Morgan Stanley. BMO Capital Markets maintained the shares of MDT in report on Tuesday, December 12 with “Buy” rating. Citigroup maintained Medtronic plc (NYSE:MDT) on Thursday, February 22 with “Buy” rating. On Thursday, May 24 the stock rating was maintained by Needham with “Buy”. As per Friday, May 25, the company rating was maintained by Morgan Stanley. Argus Research upgraded it to “Buy” rating and $95.0 target in Tuesday, December 12 report. The firm earned “Buy” rating on Thursday, May 24 by Bank of America. Morgan Stanley maintained Medtronic plc (NYSE:MDT) rating on Thursday, March 29. Morgan Stanley has “Equal-Weight” rating and $90 target. As per Tuesday, January 2, the company rating was upgraded by Bank of America. The firm has “Buy” rating by Piper Jaffray given on Friday, April 27.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.